
NORTH CHICAGO, Illinois — Walgreens Boots Alliance Inc (WBA.O), the owner of the Walgreens drugstore chain, reported weaker-than-expected quarterly results on Friday and gave a disappointing forecast, sending its shares down 6%.
The company said net income fell to $380 million, or $1.08 per share, in the quarter ended May 31, from $669 million, or $1.89 per share, a year earlier. Analysts on average had expected earnings of $1.10 per share, according to Refinitiv data.
Walgreens said U.S. pharmacy sales declined 3.9% due to lower sales of generic drugs and a shift in business from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. fell 2.3%.
The company's shares were down 6% at $44.60 in morning trading.
Walgreens also said it expects full-year earnings to be between $4.30 and $4.45 per share, below analysts' average estimate of $4.47 per share.
The results come as Walgreens continues to face pressure from competition in the pharmacy sector, particularly from Amazon.com Inc (AMZN.O), which has been expanding its own pharmacy services.
Walgreens Chairman and Chief Executive Officer Doug McMillon said the company is "executing against our strategic priorities" but acknowledged that "the macro environment remains challenging." (Reporting by Sanjana Sastry in Boston; Editing by Will Dunham and Nick Zieminski)
崾 complains of unsatisfactory quarterly performance and lowered its outlook, causing its shares to drop 6%.
Walgreens reported a net income of $380 million, or $1.08 per share, for the quarter ended May 31, down from $669 million, or $1.89 per share, in the same period a year earlier.
The company attributed the decline to lower U.S. pharmacy sales, which fell 3.9% due to decreased sales of generic drugs and a shift from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. decreased by 2.3%.
Walgreens also announced an outlook for full-year earnings between $4.30 and $4.45 per share, below the analysts' average estimate of $4.47 per share.
The company faces ongoing pressure from competitors like Amazon, which has been expanding its pharmacy services.
Walgreens Chairman and CEO Doug McMillon stated, "We are executing against our strategic priorities," but acknowledged the challenging macro environment.
Shares of Walgreens were trading down 6% at $44.60 in morning trading.
Walgreens #QuarterlyResults #EarningsReport #StockMarket #RetailPerformance
山东省抓项目扩投资稳增长推进会、2025年春季高质量发展重大项目建设现场推进会举行
大众新闻
您不知道的创新冠军|山东天维膜: 在0.1毫米间上演“膜”法
大众新闻·大众日报
定好闹钟!大学英语四、六级成绩明天可查
央视新闻
老铺黄金调价前夕现“抢购潮”,上市8个月股价飙升超10倍
第一财经
张家界武陵源回应“导游被指埋怨游客不购物”:立案调查,严肃处理
武陵源区文化旅游和商务局
药品追溯码归集超200亿条 买药更安心
新华社
金价飙升掀起“淘金热”:市民实测10元“淘金沙”等同智商税
封面新闻
中国载人登月瞄准哪些任务?
中国航天报微信公号
“尔滨”明年见!哈尔滨冰雪大世界将于26日闭园
人民日报微博
联合国安理会通过美国涉乌决议
央视新闻客户端